English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 13 Help

Selected(0)Clear Items/Page:    Sort:
The interrelation between interpretation biases, threat expectancies and pain-related attentional processing Journal article
Chan, Frederick H.F., Jackson, Todd, Hsiao, Janet H., Chan, Antoni B., Barry, Tom J.. The interrelation between interpretation biases, threat expectancies and pain-related attentional processing[J]. European Journal of Pain (United Kingdom), 2020, 24(10), 1956-1967.
Authors:  Chan, Frederick H.F.;  Jackson, Todd;  Hsiao, Janet H.;  Chan, Antoni B.;  Barry, Tom J.
Favorite | TC[WOS]:12 TC[Scopus]:13  IF:3.5/3.8 | Submit date：2021/12/06
Pain-related attentional processes: A systematic review of eye-tracking research Review article
2020
Authors:  Chan, Frederick H.F.;  Suen, Hin;  Jackson, Todd;  Vlaeyen, Johan W.S.;  Barry, Tom J.
Favorite | TC[WOS]:16 TC[Scopus]:17  IF:13.7/15.3 | Submit date：2021/12/06
Attentional Bias  Eye Tracking  Pain  Systematic Review  
Poly(ethylene glycol)-poly-l-glutamate complexed with polyethyleneimine-polyglycine for highly efficient gene delivery: In vitro and in vivo Journal article
Guo Z., Lin L., Chen J., Zhou X., Chan H.F., Chen X., Tian H., Chen M.. Poly(ethylene glycol)-poly-l-glutamate complexed with polyethyleneimine-polyglycine for highly efficient gene delivery: In vitro and in vivo[J]. Biomaterials Science, 2018, 6(11), 3053-3062.
Authors:  Guo Z.;  Lin L.;  Chen J.;  Zhou X.;  Chan H.F.; et al.
Favorite | TC[WOS]:12 TC[Scopus]:12 | Submit date：2018/12/27
Triphenylphosphonium-modified poly(ethylene glycol)-poly(ε-caprolactone) micelles for mitochondria- targeted gambogic acid delivery Journal article
Xu Y., Wang S., Chan H.F., Liu Y., Li H., He C., Li Z., Chen M.. Triphenylphosphonium-modified poly(ethylene glycol)-poly(ε-caprolactone) micelles for mitochondria- targeted gambogic acid delivery[J]. International Journal of Pharmaceutics, 2017, 522(1-2), 21-33.
Authors:  Xu Y.;  Wang S.;  Chan H.F.;  Liu Y.;  Li H.; et al.
Favorite | TC[WOS]:43 TC[Scopus]:46 | Submit date：2018/12/27
Gambogic Acid  Lung Cancer  Mitochondrial Targeting  Polymeric Micelles  
Triphenylphosphonium-modified Poly(ethylene glycol)-poly(ε-caprolactone) Micelles for Mitochondria-targeted Gambogic Acid Delivery. Journal article
Xu, Y., Wang, S., Chan, H.F., Liu, Y., Li, H., He, C. W., Li, Z., Chen, M.. Triphenylphosphonium-modified Poly(ethylene glycol)-poly(ε-caprolactone) Micelles for Mitochondria-targeted Gambogic Acid Delivery.[J]. International Journal of Pharmaceutics, 2017, 21-33.
Authors:  Xu, Y.;  Wang, S.;  Chan, H.F.;  Liu, Y.;  Li, H.; et al.
Favorite | TC[WOS]:43 TC[Scopus]:46  IF:5.3/5.6 | Submit date：2022/07/28
Gambogic Acid  Polymeric Micelles  Mitochondrial Targeting  Lung Cancer  
CD133 in brain tumor: The prognostic factor Journal article
Li B., McCrudden C.M., Yuen H.F., Xi X., Lyu P., Chan K.W., Zhang S.D., Kwok H.F.. CD133 in brain tumor: The prognostic factor[J]. Oncotarget, 2017, 8(7), 11144-11159.
Authors:  Li B.;  McCrudden C.M.;  Yuen H.F.;  Xi X.;  Lyu P.; et al.
Favorite | TC[WOS]:32 TC[Scopus]:39 | Submit date：2018/12/19
Brain Tumor  Cd133  Hox  Lim2  Stem Cell  
A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma Therapy. Journal article
Fang, X., Xu, Y., Chan, H.F., Wang, C., Zheng, Q., Xiao, F., Chen, M.. A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma Therapy.[J]. Molecular Pharmaceutics, 2016, 3613-3615.
Authors:  Fang, X.;  Xu, Y.;  Chan, H.F.;  Wang, C.;  Zheng, Q.; et al.
Favorite |   IF:4.5/4.6 | Submit date：2022/01/25
Hcc  Rage  Oridonin  Pluronic F68  Redox-sensitivity  
Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy Journal article
Cai Y., Xu Y., Chan H.F., Fang X., He C., Chen M.. Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy[J]. Molecular Pharmaceutics, 2016, 13(3), 699.
Authors:  Cai Y.;  Xu Y.;  Chan H.F.;  Fang X.;  He C.; et al.
Favorite | TC[WOS]:115 TC[Scopus]:120 | Submit date：2018/10/30
Anti-hcc  Delivery Systems  Ga  Liver-targeting  
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy Journal article
Wang S., Xu Y., Chan H.F., Kim H.-W., Wang Y., Leong K.W., Chen M.. Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy[J]. Journal of Controlled Release, 2016, 240, 454.
Authors:  Wang S.;  Xu Y.;  Chan H.F.;  Kim H.-W.;  Wang Y.; et al.
Favorite | TC[WOS]:42 TC[Scopus]:45  IF:10.5/10.6 | Submit date：2018/10/31
Apoptosis  Cancer  Drug Resistance  Nanoparticles  Survivin  
iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy Journal article
Zhang J., Hu J., Chan H.F., Skibba M., Liang G., Chen M.. iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy[J]. Nanomedicine: Nanotechnology, Biology, and Medicine, 2016, 12(5), 1303.
Authors:  Zhang J.;  Hu J.;  Chan H.F.;  Skibba M.;  Liang G.; et al.
Favorite | TC[WOS]:95 TC[Scopus]:105 | Submit date：2018/10/30
Active Targeting  Doxorubicin  Hepatocellular Carcinoma  Irgd Peptide  Sorafenib